Effect of Ghrelin on Hepatic IGF-Binding Protein-1 Production

Ghrelin plays key roles in energy homeostasis by central and peripheral actions that include effects on insulin signalling pathways in liver. Insulin is an important inhibitor of production by hepatocytes of insulin-like growth factor-binding protein-1 (IGFBP-1) which has an endocrine role to inhibit IGF availability. The effects of ghrelin, insulin, an AMPK activator, and an AMPK inhibitor on IGFBP-1 secretion were studied in H4-II-E rat liver cells. Ghrelin (100 nM) blocked the inhibitory effect of a maximally effective concentration of insulin (10 ng/mL) on IGFBP-1 secretion during a 5 h incubation period (P < 0.001) in the absence and presence of an AMPK inhibitor. Ghrelin, alone, had no effect on IGFBP-1 production, but enhanced secretion independently of insulin under conditions of AMPK activation (P < 0.001). In conclusion, IGFBP-1 is identified as a novel target of ghrelin action in liver that may contribute to its metabolic effects in obesity.

• Publication year

  2013

• Venue

  ISRN Obesity

• Publication date

  2013-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2013/751401PMID 24555152PMCID 3901966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women

  2012cited by this paper
• I and J

  2012cited by this paper
• Ghrelin's second life: from appetite stimulator to glucose regulator.

  2012cited by this paper
• Ghrelin and appetite control in humans--potential application in the treatment of obesity.

  2011cited by this paper
• Ghrelin and glucose homeostasis.

  2011cited by this paper
• IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women

  2010cited by this paper
• Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice

  2010cited by this paper
• Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

  2008cited by this paper
• Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance.

  2008cited by this paper
• Ghrelin Enhances in Vivo Skeletal Muscle But Not Liver AKT Signaling in Rats

  2007cited by this paper
• Facilitation of decidualization by locally produced ghrelin in the human endometrium.

  2007cited by this paper
• AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues

  2006cited by this paper
• Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice

  2006cited by this paper
• Low plasma ghrelin concentration is an indicator of the metabolic syndrome

  2006cited by this paper
• Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle.

  2005cited by this paper
• Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes.

  2005cited by this paper
• Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.

  2005cited by this paper
• Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

  2004cited by this paper
• Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

  2003cited by this paper
• The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.

  2003cited by this paper
• The Role of the Insulin-Like Growth Factors and Their Binding Proteins in Glucose Homeostasis

  2003cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

  2002cited by this paper
• High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.

  2002cited by this paper
• Elevated plasma ghrelin levels in Prader–Willi syndrome

  2002cited by this paper
• Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents.

  2002cited by this paper
• Ghrelin Modulates the Downstream Molecules of Insulin Signaling in Hepatoma Cells*

  2002cited by this paper
• Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase.

  2001cited by this paper
• Circulating ghrelin levels are decreased in human obesity.

  2001cited by this paper
• Ghrelin induces adiposity in rodents

  2000cited by this paper
• Role of insulin-like growth factor binding protein 1 in human pregnancy.

  1999cited by this paper
• Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species.

  1999cited by this paper
• Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo.

  1995cited by this paper
• Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.

  1992cited by this paper
• Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?

  1991cited by this paper

• Alleviation of glyphosate-induced toxicity by Horseradish tree (Moringa oleifera) Leaf extract and phytase in Nile Tilapia (Oreochromis niloticus) highlighting the antioxidant, anti-inflammatory, and anti-apoptotic activities

  2025cites this paper
• Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes

  2019cites this paper
• Red pepper seed water extract suppresses high-fat diet-induced obesity in C57BL/6 mice

  2019cites this paper
• The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity

  2017cites this paper
• The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus

  2014cites this paper